C. Neil Lyons serves as Executive at REGENERX BIOPHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, C. Neil Lyons has executed 4 insider transactions totaling $5.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 26, 2012 involved receiving (via award) 20,273 shares valued at $0.
C. Neil Lyons currently holds 20,273 shares of REGENERX BIOPHARMACEUTICALS INC (RGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, C. Neil Lyons has been a net buyer of RGN stock. They have purchased $5.6K and sold $0 worth of shares.
C. Neil Lyons's most recent insider trade was on Jun 26, 2012, when they sold 20,273 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.28 |
| Discretionary |
| Jun 10, 2010 | RGN | $1.4K | Purchase | 5,000 | $0.28 | Discretionary |
| Aug 29, 2007 | RGN | $19.6K | Award | 10,000 | $1.96 | Discretionary |